Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled tria... von Benza, Raymond L., MD, Gomberg-Maitland, Mardi, MD, MSc, Naeije, Robert, MD, PhD, Arneson, Carl P., MStat, Lang, Irene M., MD

Volltext

The Effect of Diluent pH on Bloodstream Infection Rates in Patients Receiving IV Treprostinil for Pulmonary Arterial Hypertension von Rich, Jonathan D., MD, Glassner, Cherylanne, BS, Wade, Michael, PhD, Coslet, Sandra, RN, Arneson, Carl, PhD, Doran, Aimee, MS, Gomberg-Maitland, Mardi, MD, FCCP

Volltext

Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy for pulmonary arterial hypertension: A placebo-controlled trial von Hiremath, Jagdish, MD, Thanikachalam, Sadagopa, MD, Parikh, Keyur, MD, Shanmugasundaram, Somasundaram, MD, Bangera, Sudhakar, MD, Shapiro, Leland, MD, Pott, Gregory B., PhD, Vnencak-Jones, Cindy L., PhD, Arneson, Carl, MStat, Wade, Michael, PhD, White, R. James, MD, PhD

Volltext

Beraprost therapy for pulmonary arterial hypertension von Barst, Robyn J, McGoon, Michael, McLaughlin, Vallerie, Tapson, Victor, Oudiz, Ronald, Shapiro, Shelley, Robbins, Ivan M, Channick, Richard, Badesch, David, Rayburn, Barry K, Flinchbaugh, Robin, Sigman, Jeff, Arneson, Carl, Jeffs, Roger

Volltext

Pharmacokinetics and Steady-State Bioequivalence of Treprostinil Sodium (Remodulin®) Administered by the Intravenous and Subcutaneous Route to Normal Volunteers von Laliberte, Kevin, Arneson, Carl, Jeffs, Roger, Hunt, Thomas, Wade, Michael

Volltext

Dose Proportionality of Treprostinil Sodium Administered by Continuous Subcutaneous and Intravenous Infusion von McSwain, C. Shane, Benza, Ray, Shapiro, Shelley, Hill, Nicholas, Schilz, Robert, Elliott, C. Gregory, Zwicke, Diann L., Oudiz, Ronal J., Staszewski, Jame P., Arneson, Car P., Wade, Michael, Zaccardelli, David, McLaughlin, Vallerie

Volltext

Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients Receiving Background Endothelin Receptor Antagonist and Phosphodiesterase Type 5 Inhibitor Therap... von Tapson, Victor F., MD, FCCP, Jing, Zhi-Cheng, MD, FCCP, Xu, Kai-Feng, MD, Pan, Lei, MD, Feldman, Jeremy, MD, FCCP, Kiely, David G., MD, Kotlyar, Eugene, MD, McSwain, C. Shane, MS, Laliberte, Kevin, PharmD, Arneson, Carl, MSTAT, Rubin, Lewis J., MD, FCCP

Volltext

Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients on Background Endothelin Receptor Antagonist and/or Phosphodiesterase Type 5 Inhibitor Therapy (T... von Tapson, Victor F., MD, FCCP, Torres, Fernando, MD, Kermeen, Fiona, MD, Keogh, Anne M., MD, Allen, Roblee P., MD, FCCP, Frantz, Robert P., MD, Badesch, David B., MD, FCCP, Frost, Adaani E., MD, FCCP, Shapiro, Shelley M., MD, Laliberte, Kevin, PharmD, Sigman, Jeffrey, BA, Arneson, Carl, MStat, Galiè, Nazzareno, MD

Volltext

Treatment Satisfaction and Quality of Life in Patients Treated With Inhaled Treprostinil for Pulmonary Arterial Hypertension von Chen, Hubert, MD, Rosenzweig, Erika, MD, Gotzkowsky, Karl, PharmD, Arneson, Carl, MS, Nelsen, Andrew, PharmD, Bourge, Robert, MD

Volltext

Efficacy and Safety of Oral Treprostinil Monotherapy for the Treatment of Pulmonary Arterial Hypertension: A Randomized, Controlled Trial von JING, Zhi-Cheng, PARIKH, Keyur, ARNESON, Carl, RUBIN, Lewis J, PULIDO, Tomas, JERJES-SANCHEZ, Carlos, WHITE, R. James, ALLEN, Roblee, TORBICKI, Adam, XU, Kai-Feng, YEHLE, David, LALIBERTE, Kevin

Volltext

Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients on Background Endothelin Receptor Antagonist and/or Phosphodiesterase Type 5 Inhibitor Therapy (T... von TAPSON, Victor F, TORRES, Fernando, SIGMAN, Jeffrey, ARNESON, Carl, GALIE, Nazzareno, KERMEEN, Fiona, KEOGH, Anne M, ALLEN, Roblee P, FRANTZ, Robert P, BADESCH, David B, FROST, Adaani E, SHAPIRO, Shelley M, LALIBERTE, Kevin

Volltext

Oral treprostinil for the treatment of pulmonary arterial hypertension in patients receiving background endothelin receptor antagonist and phosphodiesterase type 5 inhibitor therap... von Tapson, Victor F, Jing, Zhi-Cheng, Xu, Kai-Feng, Pan, Lei, Feldman, Jeremy, Kiely, David G, Kotlyar, Eugene, McSwain, C Shane, Laliberte, Kevin, Arneson, Carl, Rubin, Lewis J

Volltext

FREEDOM-M: Efficacy and Safety of Oral Treprostinil Diethanolamine as Monotherapy in Patients With Pulmonary Arterial Hypertension von Rubin, Lewis, MD, Parikh, Keyur, MD, Pulido, Tomas, MD, Jerjes-Sanchez, Carlos, MD, Allen, Roblee, MD, White, James, MD, Torbicki, Adam, MD, Xu, Kaifeng, MD, Yehle, David, BS, Laliberte, Kevin, PharmD, Arneson, Carl, MS, Jing, Zhi-Cheng, MD

Volltext

Pharmacokinetics of Treprostinil Sodium Administered by 28-Day Chronic Continuous Subcutaneous Infusion von Wade, Michael, Baker, F. Jo, Roscigno, Robert, DellaMaestra, Wayne, Arneson, Carl P., Hunt, Thomas L., Lai, Allen A.

Volltext

Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock von LOPEZ, Angel, LORENTE, Jose Angel, SILVERMAN, Michael S, TAKALA, Jukka, DONALDSON, Jill, ARNESON, Carl, GROVE, Geraldine, GROSSMAN, Steven, GROVER, Robert, STEINGRUB, Jay, BAKKER, Jan, MCLUCKIE, Angela, WILLATTS, Sheila, BROCKWAY, Michael, ANZUETO, Antonio, HOLZAPFEL, Laurent, BREEN, Desmond

Volltext

Does 16-Week Response Predict Long-term Success? Results From a 52-Week Analysis of Patients Receiving 40 mg Once-Daily Tadalafil von Feldman, Jeremy P., Arneson, Carl, Wade, Micheal

Volltext

Tadalafil in Geriatric Patients With Pulmonary Arterial Hypertension von Arneson, Carl, McDevitt, Susie, Klinger, James R.

Volltext

Relationship Between Dosing and Common Adverse Events With Tadalafil in Patients With Pulmonary Arterial Hypertension von Berman Rosenzweig, Erika, Arneson, Carl, Golden, Gil

Volltext

Treatment satisfaction is associated with improved quality of life in patients treated with inhaled treprostinil for pulmonary arterial hypertension von Chen, Hubert, Rosenzweig, Erika B, Gotzkowsky, S Karl, Arneson, Carl, Nelsen, Andrew C, Bourge, Robert C

Volltext

TADALAFIL IN PATIENTS WITH COLLAGEN VASCULAR DISEASE-ASSOCIATED PULMONARY ARTERIAL HYPERTENSION von Girgis, Reda, Arneson, Carl, Wade, Michael

Volltext